U.S. equity markets extended their record-setting rally as oil prices retreated. Click here to read more about the market and ...

Cytokinetics' aficamten recently met both primary endpoints in Phase 3 ACACIA-HCM for non-obstructive HCM. Read why CYTK ...

LyondellBasell has been a reliable dividend payer for 14 years managing to increase it in each of the past 12 years. See why ...

(Note: This is a Canadian producer that reports using Canadian dollars unless otherwise noted. Also, it may be better to try ...

Pressure in the delivery segment continued to weigh on Akamai's growth and margins. Read more on AKAM stock and why it is a ...

Fidus Investment's portfolio, heavily weighted toward technology and IT services, remains healthy with 79.5% first lien debt.

CERS Q1 2026 revenue rose 24% YoY as IFC volumes jumped 120%. Here's what investors need to know about the company.

Krystal Biotech leverages its HSV-1 gene delivery platform, with VYJUVEK generating strong cash flow. Read why I rate KRYS ...

Berkshire is a hold at 1.4x book value as high cash levels and leadership shifts cap near-term gains. Find out why BRK.B ...

Colgate-Palmolive's Q1 EPS fell 6% amid weak organic growth and FX risks due to US headwinds. Learn why CL stock is a hold.

Dell is positioned to capture accelerating AI server demand as agentic AI workloads scale, supported by a growing revenue ...

Comcast is a strong buy at 7.1x P/E as Peacock nears profit and high yields offset Q1 connectivity risks. Learn more on CMCSA ...